Eli Lilly and Company

Selma Sapmaz

Charles Willis Lugar, Iii

Andrew Caerwyn Williams

Ryan Edward Stites

Maria Angeles Martinez-Grau

Timothy Ivo Richardson

Richard Edmund Rathmell

Michael Philip Mazanetz

Manuel Javier Cases-Thomas

John Richard Morphy

John Gordon Allen

Christopher Stanley Galka

Karin Briner

Natalia Pokrovskaia

Roger Ryan Rothhaar

Richard C Hoying

Magnus Wilhelm Walter

Matthew Robert Reinhard

Grant Mathews Vaught

Carlos Lamas-Peteira

Simon James Richards

John Cunningham O'Toole

Anne Marie Camp

Christian Alexander Clarke

Alicia Marcos Llorente

Helene Catherine Eugenie Rudyk

Marta Adeva Bartolome

Helene Rudyk

Karen Briner

The present invention provides novel ROR gamma-t inhibitors and pharmaceutical compositions thereof, formula (A). 

Compounds useful for inhibiting ROR&#x3b3;t

The present invention provides novel ROR gamma-t inhibitors and pharmaceutical compositions thereof. Formula (I).

Compounds useful for inhibiting ROR-gamma-t

The invention provides certain 3-substituted-6-(pyridinylmethoxy)-pyrrolopyridine compounds, particularly compounds of formula I and pharmaceutical compositions thereof. The invention further provides methods of using a compound of formula I to treat Parkinsons disease Formula (I). 

3-substituted-6-(pyridinylmethoxy)-pyrrolopyridine compounds

The present invention provides 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines of Formula (I) as selective 5-HT2c receptor agonists for the treatment of 5-HT2c associated disorders including obesity, obsessive/compulsive disorder, depression, and anxiety, where, R6 is &#x2014;NR10R11, where R10 is substituted phenylalkyl or substituted pyridylalkyl and other substituents are as defined in the specification. 

[object Object]

The present invention provides 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines of Formula (I) as selective 5-HTreceptor agonists for the treatment of 5-HTassociated disorders including obesity, obsessive/compulsive disorder, depression, and anxiety: where Ris &#x2014;C&#x2261;C&#x2014;R, &#x2014;CH&#x2550;CRR, or &#x2014;(C-C)alkyl-Aroptionally substituted on the alkyl moiety with 1 to 6 fluoro substituents and other substituents are as defined in the specification. 

Growing community of inventors

Basingstoke, United Kingdom

Selma Sapmaz